


Ask a doctor about a prescription for IBUPROFEN MABO-FARMA 400 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Ibuprofen Mabo-Farma 400 mg Film-Coated Tablets EFG
Read all of this leaflet carefully before you start taking this medicine, because it contains important information for you.
Contents of the Package Leaflet:
Ibuprofen, the active substance in this medicine, acts by reducing pain and fever.
It is indicated in adults and adolescents from 12 years old and weighing more than 40 kg for the symptomatic relief of occasional mild or moderate pain, such as headache, dental, menstrual, muscular (cramps) or back (lumbago) pain, as well as in febrile conditions.
You should consult a doctor if it worsens or does not improve, if the fever persists for more than 3 days or the pain for more than 3 days in adolescents or 5 days in adults.
Do not take Ibuprofen Mabo-Farma
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting to take this medicine.
Inform your doctor:
It is important that you use the smallest dose that relieves-controls the pain and do not take this medicine for longer than necessary to control your symptoms.
Precautions in elderly patients
Elderly patients have a higher frequency of adverse reactions to NSAIDs, especially gastrointestinal bleeding and perforation, which can be fatal.
Skin reactions
Severe skin reactions have been reported in association with Ibuprofen Mabo-Farma treatment. Stop taking Ibuprofen Mabo-Farma and consult your doctor immediately if you experience any skin rash, lesions on the mucous membranes, blisters, or other signs of allergy, as these may be the first signs of a severe skin reaction. See section 4.
Severe skin reactions, such as exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), and acute generalized exanthematous pustulosis (AGEP), have been reported in association with ibuprofen treatment. Discontinue ibuprofen treatment and seek medical attention immediately if you notice any symptoms related to these severe skin reactions described in section 4.
Cardiovascular precautions
Anti-inflammatory/analgesic medications like ibuprofen may be associated with a small increased risk of heart attack or stroke, especially when used in high doses. Do not exceed the recommended dose or treatment duration.
You should discuss your treatment with your doctor or pharmacist before taking this medicine if:
Similarly, this type of medication may cause fluid retention, especially in patients with heart failure and/or high blood pressure (hypertension).
Ibuprofen has been reported to cause allergic reactions to ibuprofen, such as respiratory problems, swelling of the face and neck (angioedema), and chest pain. Stop using ibuprofen immediately and contact your doctor or emergency medical services immediately if you notice any of these signs.
Respiratory disorders
Ibuprofen should be used with caution when administered to patients who have or have a history of bronchial asthma, chronic rhinitis, or allergic diseases, as ibuprofen has been reported to cause bronchospasm, urticaria, or angioedema in such patients.
Infections
Ibuprofen may mask the signs of an infection, such as fever and pain. Consequently, this medicine may delay appropriate treatment of the infection, which may increase the risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections related to chickenpox. If you take this medicine while having an infection and the symptoms of the infection persist or worsen, consult a doctor without delay.
Precautions during pregnancy and in women of childbearing age
Because the administration of ibuprofen-like medications has been associated with an increased risk of congenital anomalies/abortions, it is not recommended to administer it during the first and second trimester of pregnancy unless it is strictly necessary. In these cases, the dose and duration will be limited to the minimum possible. The risk is believed to increase with the dose and duration of treatment.
In the third trimester, the administration of ibuprofen is contraindicated.
For women of childbearing age, it should be taken into account that ibuprofen-like medications have been associated with a decrease in fertility.
Adolescents
There is a risk of kidney damage in dehydrated adolescents.
Other medications and Ibuprofen Mabo-Farma
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.
The following medications may interfere and should not be taken with ibuprofen without consulting your doctor first:
Other medications may also affect or be affected by ibuprofen treatment. Therefore, you should always consult your doctor or pharmacist before using ibuprofen with other medications.
Interference with laboratory tests
Taking ibuprofen may alter the following laboratory tests:
If you are going to undergo any diagnostic test (including blood tests, urine tests, skin tests using allergens, etc.), inform your doctor that you are taking this medicine, as it may alter the results.
Taking Ibuprofen Mabo-Farma with food, drink, and alcohol
You can take it alone or with food. In general, it is recommended to take it during meals to reduce the possibility of stomach discomfort.
If you drink alcohol while being treated with this medicine, you may be more prone to side effects.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Ibuprofen should not be taken during pregnancy, especially during the third trimester (see section precautions during pregnancy and in women of childbearing age).
Fertility
The use of this medicine is not recommended in women who are trying to become pregnant.
Breastfeeding
Although only small amounts of the medicine pass into breast milk, it is recommended to consult a doctor in cases of long-term treatment or high doses during breastfeeding.
Driving and using machines
If you experience dizziness, vertigo, vision changes, or other symptoms while taking this medicine, you should not drive or use machinery.
If you only take one dose of ibuprofen or for a short period, it is not necessary to take special precautions.
Ibuprofen may delay your reaction time, which should be taken into account before performing activities that require greater vigilance, such as driving and using machinery.
This applies to a greater extent to the combination with alcohol.
Ibuprofen Mabo-Farma contains lactose
If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Ibuprofen Mabo-Farma contains sodium
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially "sodium-free".
Follow the administration instructions for this medication contained in this prospectus or as indicated by your doctor. In case of doubt, ask your doctor, pharmacist, or nurse.
The effective lowest dose should be used for the shortest time necessary to relieve symptoms. If you have an infection, consult your doctor immediately if symptoms (such as fever and pain) persist or worsen (see section 2). The recommended dose is:
Adults and adolescents (over 40 kg in weight) from 12 years:
Take one tablet (400 mg) every 6 to 8 hours, if necessary. Do not take more than 3 tablets (1200 mg) within 24 hours.
Use in children and adolescents:
The use of this medication is not recommended in children or adolescents under 40 kg in weight, as the dose of ibuprofen it contains is not suitable for the recommended dosage in this group of patients.
Elderly patients (over 65 years):
The dosage should be established by the doctor, as there may be a need for a reduction in the usual dose. Elderly people are often more prone to adverse effects, so sometimes the dose needs to be reduced. Consult your doctor.
Patients with kidney, liver, and/or heart disease:
In patients with mild or moderate disease, the dose should be reduced. Ibuprofen should not be used in patients with severe renal, hepatic, or cardiac insufficiency.
Method of administration:
This medication is administered orally.
Patient with stomach upset should take the medication with milk and/or during meals.
Take ibuprofeno with sufficient water. The tablets should be swallowed whole, with a glass of water, without chewing, breaking, crushing, or sucking to avoid discomfort in the mouth and throat irritation.
It is essential to use the smallest dose that relieves/controls pain and not take ibuprofeno for longer than necessary to control symptoms.
If you think the action of this medication is too strong or too weak, inform your doctor or pharmacist.
If you take more Ibuprofeno Mabo-Farma than you should
If you have taken more ibuprofen than you should or if a child has accidentally ingested the contents of the package, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 5620420, indicating the medication and the amount ingested. It is recommended to bring the package and the prospectus of the medication to the healthcare professional.
Normally, symptoms of overdose occur 4 to 6 hours after taking ibuprofen.
Symptoms of overdose may include nausea, stomach pain, vomiting (which may contain bloody sputum), gastrointestinal bleeding (see also section 4), diarrhea, indifference, sleep, headache, ringing in the ears, confusion, lack of muscle coordination, and involuntary eye movements.
It is rare for more severe symptoms to appear, such as decreased body temperature, metabolic acidosis, convulsions, altered kidney function, coma, adult respiratory distress, and transient respiratory arrest in children (after ingesting large amounts). Agitation, somnolence, disorientation, or coma may also occur. Occasionally, patients develop convulsions.
At high doses, symptoms of somnolence, chest pain, palpitations, loss of consciousness, convulsions (mainly in children), weakness, and dizziness, blood in the urine, low potassium levels in the blood, chills, and breathing problems have been reported.
Additionally, the prothrombin time/INR is likely to be prolonged due to the interaction with circulating coagulation factors. Acute kidney failure and liver damage may occur. Exacerbation of asthma in asthmatics is possible. Additionally, hypotension and decreased respiration may occur.
If a severe poisoning has occurred, the doctor will take the necessary measures.
If you forgot to take Ibuprofeno Mabo-Farma
Do not take a double dose to make up for forgotten doses.
If you forget to take your corresponding dose, take it as soon as you remember. However, if the time of the next dose is very close, skip the forgotten dose and take the next dose at the usual time.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause adverse effects, although not all people suffer from them.
Adverse effects of medications like ibuprofen are more common in people over 65 years old.
The incidence of adverse effects is lower in short treatments and if the daily dose is below the maximum recommended dose.
The following adverse effects have been observed:
Uncommon adverse effects(may affect up to 1 in 100 people): Gastritis, duodenal ulcers, gastric ulcers, skin redness, itching or tingling of the skin, urticaria, purpura (purple spots on the skin), skin reactions due to light influence, hypersensitivity, paresthesia (sensation of numbness, tingling, or burning, more frequent in hands, feet, arms, or legs), and somnolence, insomnia, anxiety, hearing disorders, vision changes, rhinitis (inflammation of the nasal mucosa), inflammation of the oral mucosa with ulcer formation (mouth sores), gastrointestinal perforations, hepatitis (liver inflammation), liver function anomalies, and jaundice (yellowing of the skin and eyes), asthma, bronchospasm, dyspnea (difficulty breathing). Nephritis (kidney disorder), nephrotic syndrome (disorder characterized by protein in the urine and body swelling), and kidney failure. Acute kidney failure and papillary necrosis (especially with prolonged use) associated with increased urea.
Disorientation or confusion, depression, irritability, nervousness, psychotic reaction, vertigo, tinnitus (ringing or sounds in the ear), hearing impairment, amblyopia (vision impairment), liver damage, edema (swelling caused by fluid accumulation in tissues), optic neuritis, anaphylactic reaction (in case of severe generalized hypersensitivity reaction, swelling of the face, tongue, and larynx, dyspnea, tachycardia, hypotension, anaphylaxis, or severe shock may occur), aseptic meningitis (inflammation of the meninges, which are the membranes that protect the brain and spinal cord, not caused by bacteria). In most cases where aseptic meningitis has been reported with ibuprofen, the patient suffered from some form of autoimmune disease (such as systemic lupus erythematosus and other collagen diseases), which was a risk factor. The symptoms of aseptic meningitis observed were neck stiffness, headache, nausea, vomiting, fever, or disorientation. Other adverse effects are decreased platelets, decreased white blood cells (may manifest as frequent infections with fever, chills, or sore throat), decreased red blood cells (may manifest as difficulty breathing and skin pallor), neutropenia (decrease in neutrophils), and agranulocytosis (significant decrease in neutrophils), aplastic anemia (bone marrow failure to produce different types of cells), hemolytic anemia (premature destruction of red blood cells). The first symptoms are: fever, sore throat, superficial ulcers in the mouth, pseudogripal symptoms, extreme fatigue, bleeding, and bruises of unknown cause.
Pancreatitis, prolonged bleeding time, lupus erythematosus (joint pain and fever), severe bullous reactions including Stevens-Johnson syndrome (widespread erosions affecting the skin and at least two mucous membranes and lesions of purple color, preferably on the trunk) and toxic epidermal necrolysis (erosions on mucous membranes and painful lesions with necrosis and shedding of the epidermis), erythema multiforme (skin lesion), hair loss, erythema multiforme. Exceptionally, severe skin infections and soft tissue complications may occur during chickenpox. Liver failure, heart failure, myocardial infarction, hypertension.
Exacerbation of inflammation-related infections has been observed coinciding with the use of NSAIDs. If signs of infection or worsening of symptoms occur during the use of ibuprofen, it is recommended to consult a doctor as soon as possible.
Exacerbation of colitis and Crohn's disease (chronic disease in which the immune system attacks the intestine, causing inflammation that usually produces diarrhea with blood). The skin becomes sensitive to light. Generalized red and scaly rash, with bumps under the skin and blisters, accompanied by fever. The symptoms usually appear at the start of treatment (acute generalized exanthematous pustulosis). Stop taking Ibuprofeno Mabo-Farma if you experience these symptoms and seek medical attention immediately. See also section 2.
Chest pain, which can be a sign of a potentially severe allergic reaction called Kounis syndrome.
If any of the following adverse effects occur, discontinue treatment and consult your doctor immediately:
Reporting adverse effects
If you experience any adverse effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Store below 30°C.
Do not use this medication after the expiration date shown on the package after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through wastewater or household waste. Deposit the packages and medications you no longer need in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packages and medications you no longer need. This will help protect the environment.
Composition of Ibuprofeno Mabo-Farma:
Appearance of the product and package contents
Oval, biconvex, white tablets.
They are presented in packages of 20 tablets in PVC/PVdC/Al blister packs.
Marketing authorization holder and manufacturer
Marketing authorization holder:
MABO-FARMA S.A.
Vía de los Poblados, 3, Edificio 6
28033 Madrid,
Spain.
Manufacturer:
Farmalider, S.A.
C/Aragoneses, 2
28108 Alcobendas (Madrid)
Spain
FROSST IBÉRICA, S.A.
Vía Complutense, 140
28805 Alcalá de Henares, Madrid
Spain
TOLL MANUFACTURING SERVICES S.L.
C/Aragoneses, 2
28108 Alcobendas (Madrid)
Spain
Date of the last revision of this prospectus:November2024
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for IBUPROFEN MABO-FARMA 400 mg FILM-COATED TABLETS – subject to medical assessment and local rules.